Indeed, tumor-specific Th9IL-4+IL-1β cells displayed significantly higher tumor-specific killing activity compared to classic Th9IL-4+TGF-β and Th2 cells in the in vitro cytolytic killing assay (Fig. 5e, f and Supplementary Figure 12a). Here, IL1B is linked to neoplasm.